Literature DB >> 29578983

ACOG Committee Opinion No. 732 Summary: Influenza Vaccination During Pregnancy.

.   

Abstract

Influenza vaccination is an essential element of prepregnancy, prenatal, and postpartum care because influenza can result in serious illness, including a higher chance of progressing to pneumonia, when it occurs during the antepartum or postpartum period. In addition to hospitalization, pregnant women with influenza are at increased risk of intensive care unit admission and adverse perinatal and neonatal outcomes. The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend that all adults receive an annual influenza vaccine and that women who are or will be pregnant during influenza season receive an inactivated influenza vaccine as soon as it is available. In the United States, the influenza season typically occurs from October to May. Ideally, an influenza vaccination should be given before the end of October, but vaccination throughout the influenza season is encouraged to ensure protection during the period of circulation. Any of the licensed, recommended, age-appropriate, inactivated influenza vaccines can be given safely during any trimester. Therefore, it is critically important that obstetrician-gynecologists and other obstetric care providers recommend and advocate for the influenza vaccine. Obstetrician-gynecologists are encouraged to stock and administer the influenza vaccine to their pregnant patients in their offices, and should get the influenza vaccine themselves every season. If the influenza vaccine cannot be offered in a practice, obstetrician-gynecologists and obstetric care providers should refer patients to another health care provider, pharmacy, or community vaccination center. This updated Committee Opinion includes more recent data on the safety and efficacy of influenza vaccination during pregnancy and recommendations for treatment and postexposure chemoprophylaxis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29578983     DOI: 10.1097/AOG.0000000000002586

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Low awareness of influenza vaccination among pregnant women and their obstetricians: a population-based survey in Beijing, China.

Authors:  Jing Wang; Dianqin Sun; Xiayidanmu Abudusaimaiti; Sten H Vermund; Dongliang Li; Yifei Hu
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

2.  COVID-19 and Pregnancy: A public health, evidence-based approach.

Authors:  Connie Newman; Cassandra Henderson; Danielle Laraque-Arena
Journal:  J Natl Med Assoc       Date:  2021-12-16       Impact factor: 1.798

3.  Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.

Authors:  James T Peterson; Agnieszka M Zareba; David Fitz-Patrick; Brandon J Essink; Daniel A Scott; Kena A Swanson; Dhawal Chelani; David Radley; David Cooper; Kathrin U Jansen; Philip R Dormitzer; William C Gruber; Alejandra Gurtman
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

4.  Evaluating adherence to American College of Obstetricians and Gynecologists guidelines at the first obstetric visit.

Authors:  Diane Christopher; Amy Markese; Shawna Tonick; Lauren Carpenter; Margo S Harrison
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

5.  Coverage and Timing of Influenza Vaccination Among Privately Insured Pregnant Women in the United States, 2010-2018.

Authors:  Kai Hong; Megan C Lindley; Fangjun Zhou
Journal:  Public Health Rep       Date:  2021-06-23       Impact factor: 3.117

6.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Karen R Broder; Emmanuel B Walter; Alicia M Fry; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2018-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.